30 Sept 2026, 16:53
Securities Administration—
PABPATRYS LIMITED
Announcement history available from 1 August 2025
Fromto
29 Sept 2026, 08:13
Company UpdateMS
28 Sept 2026, 17:32
Financial ResultsMS
28 Sept 2026, 17:32
Financial Results—
28 Sept 2026, 17:26
Company Administration—
23 Sept 2026, 08:57
Company UpdateMS
17 Sept 2026, 08:32
Company UpdateMS
31 Aug 2026, 19:03
Financial ResultsMS
28 Aug 2026, 08:12
Company UpdateMS
27 July 2026, 08:28
PresentationsMS
22 July 2026, 09:35
Quarterly ReportsMS
15 July 2026, 18:13
Securities Administration—
15 July 2026, 18:12
Securities Administration—
15 July 2026, 18:08
Securities Administration—
13 July 2026, 08:22
Company UpdateMS
7 July 2026, 18:14
Substantial Holders—
3 July 2026, 18:14
Director Interests—
3 July 2026, 18:11
Securities Administration—
3 July 2026, 18:09
Securities Administration—
3 July 2026, 18:06
Securities Administration—
9 June 2026, 08:28
Securities Administration—
9 June 2026, 08:26
Meetings & Governance—
20 May 2026, 09:31
Company UpdateMS
15 May 2026, 18:20
Quarterly Reports—
6 May 2026, 08:17
Meetings & Governance—
6 May 2026, 08:17
Meetings & Governance—
30 Apr 2026, 09:13
Quarterly ReportsMS
29 Apr 2026, 08:48
Securities Administration—
29 Apr 2026, 08:44
Securities Administration—
20 Apr 2026, 09:31
Securities Administration—
20 Apr 2026, 09:31
Capital RaisingMS
16 Apr 2026, 08:53
Trading Halt / SuspensionMS
31 Mar 2026, 08:21
PresentationsMS
18 Mar 2026, 19:36
Securities Administration—
13 Mar 2026, 18:34
Securities Administration—
11 Mar 2026, 08:23
Company UpdateMS
26 Feb 2026, 18:12
Financial ResultsMS
16 Feb 2026, 08:13
Company Administration—
12 Feb 2026, 08:13
Company AdministrationMS
10 Feb 2026, 19:17
Director Interests—
10 Feb 2026, 19:11
Securities Administration—
10 Feb 2026, 19:10
Securities Administration—
10 Feb 2026, 19:05
Securities Administration—
2 Feb 2026, 18:31
Director Interests—
30 Jan 2026, 08:17
Quarterly ReportsMS
29 Jan 2026, 08:18
Securities Administration—
29 Jan 2026, 08:18
Securities Administration—
29 Jan 2026, 08:17
Securities Administration—
28 Jan 2026, 09:37
Mergers & AcquisitionsMS
28 Jan 2026, 09:36
Mergers & AcquisitionsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 16:53 | Notification of cessation of securities - PAB | Securities Administration | — | 06027 | |
| 29 Sept 2026, 08:13 | Patrys Completes Cohort 1 Dosing and Follow-Up | Company Update | MS | 11001 | |
| 28 Sept 2026, 17:32 | Appendix 4E Variance Report | Financial Results | MS | 03003 | |
| 28 Sept 2026, 17:32 | Annual Report - 30 June 2025 | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 28 Sept 2026, 17:26 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 23 Sept 2026, 08:57 | First Participants Dosed in RLS-2202 Phase 1A Clinical Trial | Company Update | MS | 11001 | |
| 17 Sept 2026, 08:32 | PAB Establishes Clinical Advisory Committee | Company Update | MS | 11001, 12008 | |
| 31 Aug 2026, 19:03 | Appendix 4E - Preliminary Final Report | Financial Results | MS | 03003 | |
| 28 Aug 2026, 08:12 | Ethics Approval Secured for Phase 1A Clinical Trial | Company Update | MS | 11001 | |
| 27 July 2026, 08:28 | Investor Presentation - TechKnow Invest Roadshow | Presentations | MS | 03026 | |
| 22 July 2026, 09:35 | Appendix 4C - Quarterly - 30 June 2026 | Quarterly Reports | MS | 19004, 19009 | |
| 15 July 2026, 18:13 | Cleansing Notice | Securities Administration | — | 06018 | |
| 15 July 2026, 18:12 | Notification regarding unquoted securities - PAB | Securities Administration | — | 06021 | |
| 15 July 2026, 18:08 | Application for quotation of securities - PAB | Securities Administration | — | 06020 | |
| 13 July 2026, 08:22 | Patrys Secures 50% Revenue Share in IP Commercialisation | Company Update | MS | 11001 | |
| 7 July 2026, 18:14 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 3 July 2026, 18:14 | Change of Director's Interest Notices x4 | Director Interests | — | 02009 | |
| 3 July 2026, 18:11 | Notification regarding unquoted securities - PAB | Securities Administration | — | 06021 | |
| 3 July 2026, 18:09 | Cleansing Notice | Securities Administration | — | 06018 | |
| 3 July 2026, 18:06 | Application for quotation of securities - PAB | Securities Administration | — | 06020 | |
| 9 June 2026, 08:28 | Proposed issue of securities - PAB | Securities Administration | — | 06013 | |
| 9 June 2026, 08:26 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 20 May 2026, 09:31 | Patrys advances RLS-2202 toward Phase 1 Clinical Trial | Company Update | MS | 11001 | |
| 15 May 2026, 18:20 | Appendix 4C - Quarterly - 31 March 2026 - Updated | Quarterly Reports | — | 19003, 19008 | |
| 6 May 2026, 08:17 | Letter to Shareholders - General Meeting | Meetings & Governance | — | 08006, 16002 | |
| 6 May 2026, 08:17 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 30 Apr 2026, 09:13 | Appendix 4C - Quarterly - 31 March 2026 | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 08:48 | Cleansing Notice | Securities Administration | — | 06018 | |
| 29 Apr 2026, 08:44 | Application for quotation of securities - PAB | Securities Administration | — | 06020 | |
| 20 Apr 2026, 09:31 | Proposed issue of securities - PAB | Securities Administration | — | 06013 | |
| 20 Apr 2026, 09:31 | $3.2 million Placement to Advance Clinical Trials | Capital Raising | MS | 06003, 09014 | |
| 16 Apr 2026, 08:53 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 31 Mar 2026, 08:21 | Investor Presentation - Broker Meets Biotech | Presentations | MS | 03026 | |
| 18 Mar 2026, 19:36 | Notification of cessation of securities - PAB | Securities Administration | — | 06027 | |
| 13 Mar 2026, 18:34 | Change of Share Registry Details | Securities Administration | — | 12004 | |
| 11 Mar 2026, 08:23 | RLS-2201 Manufacturing and Regulatory Pathway Initiated | Company Update | MS | 11001 | |
| 26 Feb 2026, 18:12 | Appendix 4D - Half Year Accounts - 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 16 Feb 2026, 08:13 | CEO Commences Role | Company Administration | — | 12008 | |
| 12 Feb 2026, 08:13 | Appointment of Chief Executive Officer | Company Administration | MS | 12019 | |
| 10 Feb 2026, 19:17 | Change of Director's Interest Notice - BL | Director Interests | — | 02009 | |
| 10 Feb 2026, 19:11 | Cleansing Notice | Securities Administration | — | 06018 | |
| 10 Feb 2026, 19:10 | Notification regarding unquoted securities - PAB | Securities Administration | — | 06021 | |
| 10 Feb 2026, 19:05 | Application for quotation of securities - PAB | Securities Administration | — | 06020 | |
| 2 Feb 2026, 18:31 | Initial Director's Interest Notice x2 | Director Interests | — | 02008 | |
| 30 Jan 2026, 08:17 | Appendix 4C - Quarterly - 31 December 2025 | Quarterly Reports | MS | 19002, 19007 | |
| 29 Jan 2026, 08:18 | Notification regarding unquoted securities - PAB | Securities Administration | — | 06021 | |
| 29 Jan 2026, 08:18 | Application for quotation of securities - PAB | Securities Administration | — | 06020 | |
| 29 Jan 2026, 08:17 | Cleansing Prospectus | Securities Administration | — | 06010 | |
| 28 Jan 2026, 09:37 | Investor Presentation | Mergers & Acquisitions | MS | 03026, 07001 | |
| 28 Jan 2026, 09:36 | Completion of Acquisition and Board Appointments | Mergers & Acquisitions | MS | 07001, 12001 |
1–50 of 90
1 / 2